Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

GUARDANT HEALTH, INC.

(GH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies

Guardant Health to Participate in Upcoming August Investor Conferences

08/10/2020 | 08:06am EDT

REDWOOD CITY, Calif., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Guardant Health, Inc. (Nasdaq: GH) today announced the company will be participating in the following investor virtual conferences.

  • UBS Genomics 2.0 and Medtech Innovations Summit
    Fireside Chat on Tuesday, August 11th at 9 a.m. Pacific Time / 12 p.m. Eastern Time

  • Canaccord Virtual Growth Conference
    Fireside Chat on Thursday, August 13th at 1 p.m. Pacific Time / 4 p.m. Eastern Time

Interested parties may access a live and archived webcast of the presentation on the “Investors” section of the company website at: www.guardanthealth.com.

About Guardant Health
Guardant Health is a leading precision oncology company focused on helping conquer cancer globally through use of its proprietary blood tests, vast data sets and advanced analytics. The Guardant Health Oncology Platform leverages capabilities to drive commercial adoption, improve patient clinical outcomes and lower healthcare costs across all stages of the cancer care continuum. Guardant Health has launched liquid biopsy-based Guardant360® and GuardantOMNI® tests for advanced stage cancer patients. These tests fuel development of its LUNAR program, which aims to address the needs of early stage cancer patients with neoadjuvant and adjuvant treatment selection, cancer survivors with surveillance, asymptomatic individuals eligible for cancer screening and individuals at a higher risk for developing cancer with early detection.

Investor Contact:
Carrie Mendivil
investors@guardanthealth.com

Media Contact:
Anna Czene
press@guardanthealth.com

Primary Logo


ę GlobeNewswire 2020
All news about GUARDANT HEALTH, INC.
06/15GUARDANT HEALTHá : Raymond James Initiates Coverage on Guardant Health With Mark..
MT
06/08GUARDANT HEALTHá : Announces Appointment of Chris Freeman as Chief Commercial Of..
BU
06/04GUARDANT HEALTHá : Says New Data Confirms LUNAR-2 Blood Test 'Highly Accurate' f..
MT
06/04GUARDANT HEALTHá : Presents Data at 2021 ASCO Annual Meeting Showing Blood Test ..
BU
06/03GUARDANT HEALTHá : Goldman Sachs Starts Guardant Health at Buy With $160 Price T..
MT
05/28GUARDANT HEALTHá : Guardant360 Dx Approved by FDA as First Companion Diagnostic ..
MT
05/28GUARDANT HEALTHá : Guardant360« CDx Receives FDA Approval as First and Only Liqu..
BU
05/28GUARDANT HEALTHá : Sues California-Based Natera for Making 'Misleading' Statemen..
MT
05/28GUARDANT HEALTHá : Files Lawsuit Against Natera for Misleading Oncologists
BU
05/25GUARDANT HEALTHá : Wells Fargo Starts Guardant Health at Overweight With $145 Pr..
MT
More news
Financials (USD)
Sales 2021 368 M - -
Net income 2021 -352 M - -
Net cash 2021 246 M - -
P/E ratio 2021 -35,0x
Yield 2021 -
Capitalization 12 508 M 12 508 M -
EV / Sales 2021 33,3x
EV / Sales 2022 24,3x
Nbr of Employees 864
Free-Float 95,6%
Chart GUARDANT HEALTH, INC.
Duration : Period :
Guardant Health, Inc. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends GUARDANT HEALTH, INC.
Short TermMid-TermLong Term
TrendsNeutralBearishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus BUY
Number of Analysts 15
Average target price 165,08 $
Last Close Price 123,69 $
Spread / Highest target 57,7%
Spread / Average Target 33,5%
Spread / Lowest Target -28,0%
EPS Revisions
Managers and Directors
NameTitle
Helmy Eltoukhy Chief Executive Officer & Director
AmrAli H. Talasaz Chairman, President & Chief Operations Officer
Michael Bell Chief Financial Officer
Kumud Kalia Chief Information Officer
Darya Chudova Senior Vice President-Technology
Sector and Competitors
1st jan.Capitalization (M$)
GUARDANT HEALTH, INC.-4.03%12 508
EXACT SCIENCES CORPORATION-4.22%21 770
BGI GENOMICS CO., LTD.-7.47%7 373
INVITAE CORPORATION-22.75%6 455
ADAPTIVE BIOTECHNOLOGIES CORPORATION-32.66%5 587
CAREDX, INC27.54%4 810